Someone asked me that question and rather than having to answer her then, I prefer to bring it into the open.
Is PGL trying to get a Partner or is a potential Partner making approaches?
All I can say is I won't be surprised if some discussion is taking place.
After all, now the FDA has granted PGL's drug PI-88 Orphan Drug Status, interest must be growing.
There are a number of trials going at the moment but the Melanoma trial is the one I am really interested in.
If it shows the same measure of success than the preceding one, then yes, there is a possibility that PGL may get a concession from the FDA even prior to completing Phase II.
And there is no need to wait for results from other trials because a Pharma can be selected based on MELANOMA only.
Any other results can be used in separate negotiations either with the same Pharma, a different one or others selected on a regional basis.
Investors should be aware that this is my opinion, others may think differently.
Gerry
Readers, please do your own research and you decide if and when to buy, hold or sell any stocks.
Add to My Watchlist
What is My Watchlist?